MassMutual Private Wealth & Trust’s Nektar Therapeutics NKTR Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.4K	Buy	106 +28	+36%	+$2.05K	﹤0.01%	1529
2026 Q1	$5.61K	Buy	78 +33	+73%	+$1.88K	﹤0.01%	1629
2025 Q4	$1.9K	Sell	45 -19	-30%	-$1.06K	﹤0.01%	2006
2025 Q3	$3.64K	Buy	+64	New	+$2.12K	﹤0.01%	1794
2023 Q1	–	Sell	-53	Closed	-$2K	–	1862
2022 Q4	$2K	Buy	53 +14	+36%	+$678	﹤0.01%	1292
2022 Q3	$2K	Buy	+39	New	+$2.32K	﹤0.01%	1251
2022 Q1	–	Sell	-10	Closed	-$2K	–	1600
2021 Q4	$2K	Buy	+10	New	+$2.17K	﹤0.01%	1112

Other funds holding NKTR

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Gainplan Bloomfield Hills, Michigan $254M AUM 25.62% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

LVW Advisors Pittsford, New York $1.16B AUM 26.37% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return

MassMutual Private Wealth & Trust's NKTR Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Nektar Therapeutics (NKTR) stake by 36% in Q2 2026, buying an estimated $2.05K and bringing the position to 106 shares worth $7.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1529.

MassMutual Private Wealth & Trust first reported a position in NKTR in Q4 2021 and has held it in 7 quarters since. 11 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

MassMutual Private Wealth & Trust held 106 shares of Nektar Therapeutics worth $7.4K as of Q2 2026.
MassMutual Private Wealth & Trust bought 28 Nektar Therapeutics shares in Q2 2026, an estimated $2.05K.
Nektar Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1529 holding.
MassMutual Private Wealth & Trust first reported a position in Nektar Therapeutics in Q4 2021 and has held it in 7 quarters since.
11 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.